An individual on Thursday divested a 2 per cent stake in pharmaceutical company Eris Lifesciences for a little over Rs 188 crore through an open market transaction.
According to the block deal data available with the National Stock Exchange (NSE), Rakesh Shah disposed of 27 lakh shares, amounting to a 1.98 per cent stake in Eris Lifesciences.
The shares were sold at an average price of Rs 697 apiece, taking the aggregate transaction size to Rs 188.19 crore.
Post the latest transaction, Rakesh Shah's shareholding has dropped to 9.55 per cent from 11.53 per cent stake at the end of the March quarter.
Also read: Portfolio expansion. Eris Lifesciences buys nine dermatology brands from Dr. Reddy’s for $33 million
HDFC Mutual Fund acquired 20.25 lakh shares.
Shares of Eris Lifesciences rose 1.60 per cent to close at Rs 709 per piece on the NSE.
In a separate transaction, Satpal Khattar sold 33 lakh shares of IIFL Finance for over Rs 168 crore through an open market transaction, as per the bulk deal data available with the NSE.
The shares were offloaded at an average price of Rs 510.03 apiece, taking the transaction value to Rs 168.31 crore.
Details of the buyers could not be ascertained.
On Thursday, shares of IIFL Finance gained nearly 1 per cent to settle at Rs 512.60 per piece on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.